Campbell BCV, Khatri P. Stroke. Lancet. 2020;396(10244):129–42.

Article  PubMed  Google Scholar 

Boehme AK, Esenwa C, Elkind MSV. Stroke risk factors, genetics, and prevention. Circ Res. 2017;120(3):472.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Tsao CW. Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association. Circulation. 2020;141(9):e139–596.

Gall SL, Feigin V, Thrift AG, Kleinig TJ, Cadilhac DA, Bennett DA, et al. Personalized knowledge to reduce the risk of stroke (PERKS-International): Protocol for a randomized controlled trial. Int J Stroke. 2023;18(4):477–83.

Article  PubMed  Google Scholar 

Erkent I, Topcuoglu MA, Sorgun MH, BaturCaglayan HZ, TogayIsikay C, Nazliel B, et al. Determinants of preventable stroke-Ankara ACROSS stroke preventability study. J Stroke Cerebrovasc Dis. 2020;29(7): 104825.

Article  PubMed  Google Scholar 

Crudele L, De Matteis C, Piccinin E, Gadaleta RM, Cariello M, Di Buduo E, et al. Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis. JHEP Rep. 2023;5(1): 100627.

Article  PubMed  Google Scholar 

Hindy G, Engström G, Larsson SC, Traylor M, Markus HS, Melander O, et al. Role of Blood Lipids in the Development of Ischemic Stroke and its Subtypes: A Mendelian Randomization Study. Stroke. 2018;49(4):820–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993–2000.

Article  PubMed  Google Scholar 

Sacco RL, Benson RT, Kargman DE, Boden-Albala B, Tuck C, Lin IF, et al. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA. 2001;285(21):2729–35.

Article  CAS  PubMed  Google Scholar 

Gu X, Li Y, Chen S, Yang X, Liu F, Li Y, et al. Association of Lipids With Ischemic and Hemorrhagic Stroke: A prospective cohort study among 267 500 Chinese. Stroke. 2019;50(12):3376–84.

Article  PubMed  Google Scholar 

Li H, Qian F, Zuo Y, Yuan J, Chen S, Wu S, et al. U-shaped relationship of high-density lipoprotein cholesterol and incidence of total, ischemic and hemorrhagic stroke: a prospective cohort study. Stroke. 2022;53(5):1624–32.

Article  CAS  PubMed  Google Scholar 

Hamer M, O’Donovan G, Stamatakis E. High-density lipoprotein cholesterol and mortality: too much of a good thing? Arterioscler Thromb Vasc Biol. 2018;38(3):669–72.

Article  CAS  PubMed  Google Scholar 

Ko DT, Alter DA, Guo H, Koh M, Lau G, Austin PC, et al. High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous cardiovascular conditions: The CANHEART study. J Am Coll Cardiol. 2016;68(19):2073–83.

Article  CAS  PubMed  Google Scholar 

Madsen CM, Varbo A, Nordestgaard BG. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J. 2017;38(32):2478–86.

Article  CAS  PubMed  Google Scholar 

Hirata A, Sugiyama D, Watanabe M, Tamakoshi A, Iso H, Kotani K, et al. Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study. J Clin Lipidol. 2018;12(3):674-84.e5.

Article  PubMed  Google Scholar 

Tyagi T, Jain K, Gu SX, Qiu M, Gu VW, Melchinger H, et al. A guide to molecular and functional investigations of platelets to bridge basic and clinical sciences. Nat Cardiovasc Res. 2022;1(3):223–37.

Article  PubMed  PubMed Central  Google Scholar 

van der Stoep M, Korporaal SJA, Van Eck M. High-density lipoprotein as a modulator of platelet and coagulation responses. Cardiovasc Res. 2014;103(3):362–71.

Article  PubMed  Google Scholar 

Nofer JR, Brodde MF, Kehrel BE. High-density lipoproteins, platelets and the pathogenesis of atherosclerosis. Clin Exp Pharmacol Physiol. 2010;37(7):726–35.

Article  CAS  PubMed  Google Scholar 

Pirillo A, Catapano AL, Norata GD. Biological Consequences of Dysfunctional HDL. Curr Med Chem. 2019;26(9):1644–64.

Article  CAS  PubMed  Google Scholar 

Jialal I, Jialal G, Adams-Huet B. The platelet to high density lipoprotein -cholesterol ratio is a valid biomarker of nascent metabolic syndrome. Diabetes Metab Res Rev. 2021;37(6): e3403.

Article  CAS  PubMed  Google Scholar 

Ni J, Lv L, Wu P, Xu C. Associations between the platelet/high-density lipoprotein cholesterol ratio and likelihood of nephrolithiasis: a cross-sectional analysis in United States adults. Front Endocrinol (Lausanne). 2024;15:1289553.

Article  PubMed  Google Scholar 

Lu CF, Cang XM, Liu WS, Wang LH, Huang HY, Sang SM, et al. Association between the platelet/high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: results from NHANES 2017–2020. Lipids Health Dis. 2023;22(1):130.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–32.

Article  PubMed  Google Scholar 

Ye J, Hu Y, Chen X, Yin Z, Yuan X, Huang L, et al. Association between the weight-adjusted waist index and stroke: a cross-sectional study. BMC Public Health. 2023;23(1):1689.

Article  PubMed  PubMed Central  Google Scholar 

Zhuo S, Zhang B, Zhang J, Yang M, Yu Z. Effects of dietary inflammatory index, blood lead levels, and flavonoid intake on stroke risk in older Americans: A cross-sectional study. J Stroke Cerebrovasc Dis. 2023;32(11): 107336.

Article  PubMed  Google Scholar 

Wen X, Wang M, Xu X, Li T. Exposure to Per- and Polyfluoroalkyl Substances and Mortality in U.S. Adults: A Population-Based Cohort Study. Environ Health Perspect. 2022;130(6):67007.

Article  CAS  PubMed  Google Scholar 

Hou XZ, Lv YF, Li YS, Wu Q, Lv QY, Yang YT, et al. Association between different insulin resistance surrogates and all-cause mortality in patients with coronary heart disease and hypertension: NHANES longitudinal cohort study. Cardiovasc Diabetol. 2024;23(1):86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Disease K, Outcomes IG, Group GDW. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney International. 2021;100(4S):S1–S276.

Li H, Song L, Cen M, Fu X, Gao X, Zuo Q, et al. Oxidative balance scores and depressive symptoms: Mediating effects of oxidative stress and inflammatory factors. J Affect Disord. 2023;334:205–12.

Article  CAS  PubMed  Google Scholar 

Lv H, Wang J, Zhu Y, Hu Z, Wang Z, Qiao M, et al. Association between osteoporosis or osteopenia and taking antiplatelet agents in general US population of NHANES. Front Endocrinol (Lausanne). 2022;13: 945159.

Article  PubMed  Google Scholar 

Toth PP. Cardiology patient page. The "good cholesterol": high-density lipoprotein. Circulation. 2005;111(5):e89–91.

Keene D, Price C, Shun-Shin MJ, Francis DP. Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients. BMJ. 2014;349: g4379.

Article  PubMed  PubMed Central  Google Scholar 

Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, Tomson J, et al. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med. 2014;371(3):203–12.

Article  PubMed  Google Scholar 

Lincoff AM, Nicholls SJ, Riesmeyer JS, Barter PJ, Brewer HB, Fox KAA, et al. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease. N Engl J Med. 2017;376(20):1933–42.

Article  PubMed  Google Scholar 

Kaur N, Pandey A, Negi H, Shafiq N, Reddy S, Kaur H, et al. Effect of HDL-raising drugs on cardiovascular outcomes: a systematic review and meta-regression. PLoS ONE. 2014;9(4): e94585.

Article  PubMed  PubMed Central  Google Scholar 

Shahar E, Chambless LE, Rosamond WD, Boland LL, Ballantyne CM, McGovern PG, et al. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2003;34(3):623–31.

Article  PubMed  Google Scholar 

Kurth T, Everett BM, Buring JE, Kase CS, Ridker PM, Gaziano JM. Lipid levels and the risk of ischemic stroke in women. Neurology. 2007;68(8):556–62.

Article  CAS  PubMed  Google Scholar 

Woodward M, Barzi F, Feigin V, Gu D, Huxley R, Nakamura K, et al. Associations between high-density lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region. Eur Heart J. 2007;28(21):2653–60.

Article  CAS  PubMed  Google Scholar 

Pennlert J, Eriksson M, Carlberg B, Wiklund PG. Long-term risk and predictors of recurrent stroke beyond the acute phase. Stroke. 2014;45(6):1839–41.

Article  PubMed